NOS: Molecular Mechanisms, Clinical Aspects, Therapeutic and Monitoring Approaches
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
4
Page:
141-149
Author(s):
Sergei A. Kharitonov
Inflammatory Process in Parkinsons Disease: Role for Cytokines
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
999-1016
Author(s):
T. Nagatsu and M. Sawada
Role of the 5-HT2C Receptor in Atypical Antipsychotics: Hero or Villain?
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
5
Page:
63-66
Author(s):
Martyn Wood
Gene Therapy for Parkinsons Disease: Progress and Challenges
Journal:
Current Gene Therapy
Volume:
5
Page:
71-80
Author(s):
Qin Chen, Yi He and Keyi Yang
Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors
Journal:
Current Genomics
Volume:
6
Page:
13-37
Author(s):
E. J. Kremer
Adult Neural Stem Cell Therapy: Expansion In Vitro, Tracking In Vivo and Clinical Transplantation
Journal:
Current Drug Targets
Volume:
6
Page:
97-110
Author(s):
J. Zhu, X. Wu and H. L. Zhang
Magnetic Resonance Imaging of Iron in Parkinsons Disease
Journal:
Current Medical Imaging
Volume:
1
Page:
43-48
Author(s):
Kazuo Abe and Tachio Hikita
Subject Index to Volume 10
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
101-142
Author(s):
Bentham Science Publishers
Partial Dopamine Agonists and the Treatment of Psychosis
Journal:
Current Neuropharmacology
Volume:
3
Page:
3-8
Author(s):
Carol A. Tamminga
Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function
Journal:
Current Neuropharmacology
Volume:
3
Page:
9-34
Author(s):
Laura E. Chavez-Noriega, Michael J. Marino, Herve Schaffhauser, Una C. Campbell and P. Jeffrey Conn